Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF + plerixafor vs G-CSF + placebo for stem cell mobilization in NHL/MM
CTR20170523Phase 3Active
- Sponsor
- Hunan Wuzhoutong Pharmaceutical
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of plerixafor in non-Hodgkin lymphoma (NHL), multiple myeloma (MM), sponsored by Hunan Wuzhoutong Pharmaceutical. Started Jul 2017; status: active.
02
Drugs
plerixafor
03
Conditions
non-Hodgkin lymphoma (NHL)multiple myeloma (MM)
Beyond the preview
Go deeper on CTR20170523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170523.